FDA publishes continuous manufacturing guidance

FDA released draft guidance Tuesday to facilitate the adoption of continuous manufacturing (CM) and help early adopters navigate the application review process for drugs produced with continuous manufacturing methods.

Compared with traditional, step-wise manufacturing processes, continuous manufacturing uses modern process monitoring and controls within a single, closed system to enable a steady output of finished drug products as raw materials are continuously added to the closed system. ...